Inventor · disambiguated record
Chan-Jung Li
Also filed as: LI CHAN-JUNG
3 granted patents·6 pending applications·0 citations·filing 2016–2022
49Inventor score
Technology areasA61K
Top patents by PatentIndex Score
9 records- 0165US11241424B2Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine esterLUMOSA THERAPEUTICS CO LTD·Filed 2019·Granted Feb 8, 2022·0 cites·37 claims
- 0260US11234974B2Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine esterLUMOSA THERAPEUTICS CO LTD·Filed 2018·Granted Feb 1, 2022·0 cites·16 claims
- 0359US2022071987A1Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine esterLUMOSA THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 0457US2022362226A1Compositions and methods for treating pruritusLUMOSA THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0551US2019298702A1Compositions and methods for treating pruritusLUMOSA THERAPEUTICS CO LTD·Filed 2019·Application pending·0 cites
- 0649US10183018B2Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine esterLUMOSA THERAPEUTICS CO LTD·Filed 2016·Granted Jan 22, 2019·0 cites·6 claims
- 0748US2020179373A1Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine esterLUMOSA THERAPEUTICS CO LTD·Filed 2020·Application pending·0 cites
- 0846US2025339385A1Topical formulation of dimethylcurcuminANNJI PHARM CO LTD·Filed 2022·Application pending·0 cites
- 0943US2020030318A1Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine esterLUMOSA THERAPEUTICS CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chan-Jung Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →